Recently India celebrated Pharma Day, and is known for its world-class ce shadecosystem in The City of Hyderabad, life sciences institutions have comprehensive infrastructure and vast talents from reputed educational and bioresearch institutions. An expert said the upcoming Hyderabad Pharma City would give more encouragement to companies planning to invest in Hyderabad for both greenfield and brownfield expansion. Over the past few years, many pharma companies like Granules India, Larus Labs, MSN Laboratories, Syngen, Novartis and Sandoz have expanded significantly in Hyderabad. Many medium sized companies and startups have also undertaken expansion.
Let us briefly share your information, says Srinivas N, MD, Saville Sindia Industrial and Logistics, "Pharma companies are mostly looking for new investments in Hyderabad towards research and development and innovation centers. The city has seen significant real estate investments from the life sciences industry. Telangana is likely to attract significant investments in this sector for land acquisition, production facilities, R&D bases, built-in suite, and plug and play facilities.
However, it should be noted that many large multinational companies are signing licensing agreements for the manufacture of Kovid-19 drugs and vaccines in India. The sector is likely to attract foreign majors to set up their production and R&D bases due to the domestic market size, the 'China Plus One' strategy, incentives, low-cost skilled workers and government spending on the creation of auxiliary infrastructure.
Read this :
Incidents of liquor smuggling increased in Bihar after election announcement
Mathura case reaches court, Srikrishna Virajman asked for ownership of the birthplace
